NCT05424523View on ClinicalTrials.gov

Effectiveness and Safety of Omalizumab in Children With Allergic Asthma.

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

February 25, 2021

Primary Completion Date

June 28, 2021

Study Completion Date

June 28, 2021

Conditions
Allergic Asthma
Interventions
DRUG

Omalizumab

Patients with confirmed diagnosis of allergic asthma, who were prescribed omalizumab

Trial Locations (1)

07936-1080

Novartis Investigative Site, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY